Pluri (PLUR) Receivables (2011 - 2024)
Pluri (PLUR) reported Receivables of $44000.0 for Q2 2024, down 70.27% year-over-year from $148000.0 in Q3 2023, and down 70.27% quarter-over-quarter from $148000.0 in Q2 2023.
Pluri (PLUR) Receivables (2011 - 2024) Analysis & Trends
Pluri (PLUR) has 14 years of Receivables data on file, last reported at $44000.0 in Q2 2024.
- Receivables for Q2 2024 came in at $44000.0, down 70.27% year-over-year; the trailing twelve-month figure through Jun 2024 was $44000.0 (down 70.27% YoY), and the FY2024 annual result was $44000.0, down 70.27% from the prior year.
- Receivables declined to $44000.0 in Q2 2024 per PLUR's latest filing, from $148000.0 in the prior quarter.
- Over five years, Receivables peaked at $1.1 million in Q2 2020 and troughed at $44000.0 in Q2 2024.
- A 5-year average of $342888.9 and a median of $52000.0 in 2020 frame the typical range for Receivables.
- The sharpest annual moves came in 2020 and 2023: Receivables soared 1079.57% in 2020, then sank 84.8% in 2023.
- A 5-year view of Receivables shows it stood at $52000.0 in 2020, then soared by 1088.46% to $618000.0 in 2021, then jumped by 57.61% to $974000.0 in 2022, then slumped by 84.8% to $148000.0 in 2023, then sank by 70.27% to $44000.0 in 2024.
- Business Quant data shows PLUR's Receivables at $44000.0 in Q2 2024, $148000.0 in Q2 2023, and $974000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2023 | 148,000.00 |
| Jun 30, 2022 | 974,000.00 |
| Jun 30, 2021 | 618,000.00 |
| Mar 31, 2021 | 52,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Sep 30, 2020 | 52,000.00 |
| Jun 30, 2020 | 1.10 Mn |
| Mar 31, 2020 | 49,000.00 |
| Dec 31, 2019 | 49,000.00 |
| Sep 30, 2019 | 49,000.00 |
| Jun 30, 2019 | 93,000.00 |
| Mar 31, 2019 | 229,000.00 |
| Dec 31, 2018 | 82,000.00 |
| Sep 30, 2018 | 37,000.00 |
| Jun 30, 2018 | 65,000.00 |
| Mar 31, 2018 | 596,000.00 |
| Dec 31, 2017 | 172,000.00 |
| Sep 30, 2017 | 25,000.00 |
| Jun 30, 2017 | 1.04 Mn |